- Home
- TDS vs XENE Comparison
TDS vs XENE Comparison
Compare TDS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDS | XENE |
|---|---|---|
| Founded | 1968 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TDS | XENE |
|---|---|---|
| Price | $34.39 | $40.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 18 |
| Target Price | $47.50 | ★ $71.75 |
| AVG Volume (30 Days) | ★ 1.9M | 1.2M |
| Earning Date | 11-06-2026 | 11-09-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ 23.53 | N/A |
| EPS | ★ 3.77 | N/A |
| Revenue | ★ $1,228,207,000.00 | $311,000.00 |
| Revenue This Year | $1.06 | N/A |
| Revenue Next Year | $1.02 | $2,045.70 |
| P/E Ratio | $8.77 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.71 | $33.38 |
| 52 Week High | $49.12 | $72.66 |
Technical Indicators
Market Signals| Indicator | TDS | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 56.94 |
| Support Level | $32.46 | $33.38 |
| Resistance Level | $35.61 | $43.67 |
| Average True Range (ATR) | 2.11 | 1.31 |
| MACD | -0.08 | 0.96 |
| Stochastic Oscillator | 54.62 | 97.71 |
Price Performance
Historical ComparisonAbout TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides communications services to customers through broadband, video, voice, and wireless connections. The company has two reportable segments: TDS Telecom and Array. The majority of its revenue is generated from the TDS Telecom segment, which generates revenue by providing broadband, video, voice, and wireless services. The Array segment generates its revenue mainly by leasing tower space on Array-owned towers to customers.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.